Fred Alger Management’s Cymabay Therapeutics CBAY Stock Holding History

Fred Alger Management’s Portfolio CBAY Stock Details CBAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1,967,858	Closed	-$46.5M	–	502
2023 Q4	$46.5M	Sell	1,967,858 -204,451	-9%	-$3.64M	0.25%	84
2023 Q3	$32.4M	Buy	+2,172,309	New	+$28.8M	0.19%	114

Other funds holding CBAY

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Fred Alger Management's CBAY Position: Q1 2024 in Review

Fred Alger Management sold out of Cymabay Therapeutics (CBAY) in Q1 2024, closing a stake of 1,967,858 shares — an estimated $46.5M sold.

Fred Alger Management first reported a position in CBAY in Q3 2023 and held it in 2 quarters. The position peaked at $46.5M in Q4 2023. 1 fund tracked by Wall St. Rank holds CBAY as of Q1 2024.

Fred Alger Management reported no remaining Cymabay Therapeutics position as of Q1 2024 after selling out during the quarter.
Fred Alger Management sold 1,967,858 Cymabay Therapeutics shares in Q1 2024, an estimated $46.5M.
Fred Alger Management first reported a position in Cymabay Therapeutics in Q3 2023 and held it in 2 quarters.
Fred Alger Management's Cymabay Therapeutics position peaked at $46.5M in Q4 2023.
1 fund tracked by Wall St. Rank held Cymabay Therapeutics as of Q1 2024.

Based on Fred Alger Management's 13F filing for Q1 2024, filed 15 May 2024.